PCM
BSX icon

Perritt Capital Management’s Boston Scientific BSX Stock Holding History

Perritt Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-29
Closed -$2.83K – 109
2025
Q3 		$2.83K Hold
29
– – ﹤0.01% 274
2025
Q2 		$3.12K Hold
29
– – ﹤0.01% 287
2025
Q1 		$2.93K Buy
+29
New +$2.92K ﹤0.01% 296

Other funds holding BSX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Perritt Capital Management's BSX Position: Q4 2025 in Review

Perritt Capital Management sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 29 shares — an estimated $2.83K sold.

Perritt Capital Management first reported a position in BSX in Q1 2025 and held it in 3 quarters. The position peaked at $3.12K in Q2 2025. 1,787 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

  • Perritt Capital Management reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
  • Perritt Capital Management sold 29 Boston Scientific shares in Q4 2025, an estimated $2.83K.
  • Perritt Capital Management first reported a position in Boston Scientific in Q1 2025 and held it in 3 quarters.
  • Perritt Capital Management's Boston Scientific position peaked at $3.12K in Q2 2025.
  • 1,787 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Perritt Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.